CDYL antisense RNA 1 (CDYL-AS1)

CDYL antisense RNA 1 (CDYL-AS1) is a long non-coding RNA transcribed in the antisense direction relative to the CDYL gene. Antisense RNAs like CDYL-AS1 are involved in complex regulation of their sense gene partners, often influencing transcription via chromatin modifications, DNA methylation, or transcriptional interference. While the functional role of CDYL-AS1 itself is not characterized in detail in current literature, its molecular class suggests likely involvement in epigenetic gene regulation and potentially in developmental or disease processes if dysregulated. There is no evidence from the available sources that CDYL-AS1 is a direct therapeutic target, biomarker, or established disease gene as of the current literature. Antisense lncRNAs such as CDYL-AS1 are a rapidly evolving area of gene regulation research. While some antisense RNAs have been identified as biomarkers or therapeutic targets in cancer and neurological disorders, CDYL-AS1 itself is not listed among these and is not addressed as a pharmacologically actionable target or disease gene in current references. If your application requires only classical therapeutic targets (proteins, receptors, enzymes, etc.), CDYL-AS1 would not qualify as a direct target. If CDYL-AS1 becomes implicated in new research as a target or biomarker, these details will need to be updated based on further evidence.

Other names

CDYL-AS1

Not applicable (no approved or experimental drugs target this lncRNA)